Patents by Inventor Sabine Flicker

Sabine Flicker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180022808
    Abstract: The present invention relates to an antibody construct comprising at least one antigen binding site specific for ICAM1 and at least one antigen binding site specific for at least one allergen.
    Type: Application
    Filed: February 10, 2016
    Publication date: January 25, 2018
    Inventors: Christoph Madritsch, Sabine Flicker, Rudolf Valenta, Elisabeth Gader-Maier, Julia Eckl-Dorna, Verena Niederberger, Katharina Blatt, Peter Valent, Isabella Ellinger
  • Publication number: 20100034812
    Abstract: The present invention relates to Bet V 1 specific antibodies or fragments thereof and their use in the prevention and treatment of allergen induced diseases, wherein the antibodies block the binding of IgE to Bet V 1.
    Type: Application
    Filed: May 18, 2007
    Publication date: February 11, 2010
    Applicant: Biomay AG
    Inventors: Otto Majdic, Petra Kohl, Rudolf Valenta, Sabine Flicker, Katharina Marth, Anna Gieras
  • Patent number: 7288381
    Abstract: The present invention relates to group 2 allergen specific IgE-Fabs and whole Ig molecules as well as use thereof. More precisely, the present invention relates to grass pollen specific IgE-Fabs (Phl p2) and reagents, kits and vaccines comprising these. The invention also relates to use of group 2 specific IgE-Fabs and whole Ig for, inter alia, diagnosis, therapy and prevention of type I allergy.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: October 30, 2007
    Assignee: Phadia AB
    Inventors: Sabine Flicker, Peter Steinberger, Dietrich Kraft, Rudolf Valenta
  • Publication number: 20030082659
    Abstract: The present invention relates to group 2 allergen specific IgE-Fabs and whole Ig molecules as well as use thereof. More precisely, the present invention relates to grass pollen specific IgE-Fabs (Phl p2) and reagents, kits and vaccines comprising these. The invention also relates to use of group 2 specific IgE-Fabs and whole Ig for, inter alia, diagnosis, therapy and prevention of type I allergy.
    Type: Application
    Filed: December 21, 2001
    Publication date: May 1, 2003
    Inventors: Sabine Flicker, Peter Steinberger, Dietrich Kraft, Rudolf Valenta